| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC | Director | Stock Option (right to buy) | 6,500 | $9,360 | $1.44 | 15 Jun 2021 | Direct |
| BELLICUM PHARMACEUTICALS, INC | Director | Common Stock | 28,384 | 04 Jan 2022 | Direct | ||
| BELLICUM PHARMACEUTICALS, INC | Director | Restricted Stock Units | 0 | 04 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000162828022000415-brown-james-f-2022-01-04 | BELLICUM PHARMACEUTICALS, INC | 04 Jan 2022 | 2 | $0 | 4 | Director | 06 Jan 2022, 08:49 |
| /report/000120919121045939-brown-james-f-2021-06-15 | BELLICUM PHARMACEUTICALS, INC | 15 Jun 2021 | 1 | $0 | 4 | Director | 07 Jul 2021, 20:21 |